1Knothe H, Shah P, Kremery V, et al. Transferable resiataance to cefotaxime eofoxifin, eefamandole and cofuroxirne in clinical isolates of Klebsiella pneumoniae and Serrafia marcescens [J] . Infection, 1983, 11 (6): 315-317.
2Bradford PA. Extended speetrumbeta lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat [J] . Clin Mierobiol Rev, 2001, 14 (4): 933 -951.
6Essack SY, Hall LM, Pillay DG, et al. Complexity and diversity of Klebsiella pneumottiae stains with extended - spectrum beta - lactamases isolated in 1994 and 1996 at a teaching hospital in Durban , South Africa [J] . Antimicrob Agents Chemother, 2001, 45 (1): 88-89.
7Coque TM, Oliver A, Perez DJC. Genes encoding TEM - 4, SHV -2, and CTX - 10 extended - spectrum beta - lactamaaes are, carfled by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000)[J]. Antimicrob Agents Chemother, 2002, 45 (2): 500-510.
8Winokur PL, Canton R, Casellas JM, el at. Variations in the prevalence of strains expressing an extended - spectrum beta - lactamases phenotype and characterization of isolates from Europ, the Americas, and the Western Pacific region [J] . Clin Infect Dis, 2001., 32 (2): 94-103.
9Y Yu, W Zhou, Y Chen, et aL Epidemiologieal and antibiotic resistant study on extended - spectrum beta - laetamases producing Eschefichia coli and Klebsiella pneumonian in Zhejiang Province [J] . Chin Med J (Engl), 2002, 115 (10): 1479-1482.
1Tzzelepi E, Sofianou D. Detection of extended spectrum β-lactamase in clinical isolation of Enterobacter cloacae and Enter-obacteraerogens[J]. J Clin Microbiol, 2000,38:542-546.
3Maki DG. Risk factors for nasocomial infection in intensive care[J]. Arch Intern Med, 1989,149:30-37.
4Lautenbach E, Patal JB,Bilker WB, et al. ESBLs-producing Escherichia coli and Klebsiella pneumoniae factor for infection and impact of resistance on outcomes[J]. Clin Infect Dis,2001,32(8) :1162-1167.
5Iho S, Yamamoto T, Takahashi T,et al. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3'act directly on human NK and T cells to induce IPN-V production in vitro[J]. J Immunol, 1999,62:3642-3648.
6Collis CM, Kim MJ, Partridge SR, et al. Characterization of the class 3 integron and the site-specific recombination system it determines. J Bacteriol. 2002, 184(11 ):3017-3026.
7Goldstein C, Lee MD, Sanchez S, et al. Incidence of class 1 and 2 integrases in clinical and commensal bacteria from livestock, companion animals, and exotics, Antimicrob Agents Chemother, 2001,45(3): 723-726.
8Rowe-Magnus DA, Guerout AM, Mazel D, Bacterial resistance evolution by recruitment of super-integron gene cassettes. Mol Microbiol, 2002. 43(6): 1657- 1669.
9Jones I,A. Mclver CJ. Kim MJ. et al. The aadB gene cassette is associated with blaSHV genes in Klebsiella species producing extended spectrum beta-lactamases, Antimicrob Agents Chemother,2005, 49(2): 794-797.
10Giakkoupi P, Tzouvelekis LS, Tsakris A, et al. IBC-1, a novel integron-associated class A beta-lactamase wilh extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother. 2000, 44(9): 2247-2253.
4FJavier P e rez-P e rez, Nancy D Hanson J. Detection ofplasmid-mediated Amp C β-lactamase genes in clinical isolatesby using multiplex PCR[J].J of Clinical Microbiology,2002,40(6):2153-2162.
5HongFang, Ferda Ataker, Goran Hedin,et al. Molecularepidemiology of extended-spectrum-lactamases among Escherichiacoli isolates collected in a Swedish hospital and its associatedhealth care facilities from 2001 to 2006[J]. J of Clinical Microbiology ,2008,46⑵:707—712.
